Skip to main content

Cleofé Romagosa Pérez-Portabell

Institutions of which they are part

Main researcher
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Cleofé Romagosa Pérez-Portabell

Institutions of which they are part

Main researcher
Translational Molecular Pathology
Vall Hebron Institut de Recerca

Projects

Estandarización del diagnóstico anatomopatológico y por imagen de los cambios de transformación maligna inicial en neurofibromas de pacientes con Neurofibromatosis tipo 1

IP: Cleofé Romagosa Pérez-Portabell
Collaborators: Jordi Temprana Salvador, Jorge Pérez López, Marc Simo Perdigo, Claudia Maria Valverde Morales
Funding agency: Instituto de Salud Carlos III
Funding: 81070
Reference: PI14/00724
Duration: 01/01/2015 - 31/12/2018

Estudi sobre la viabilitat de l'anastomosi vascular microquirúrgica en població irradiada. Estudi en model animal en rata.

IP: Roberto Vélez Villa
Collaborators: Cleofé Romagosa Pérez-Portabell, César Galo García Fontecha, Manuel Llusà Pérez, Francisco Soldado Carrera, David Barastegui Fernández
Funding agency: SOCIETAT CATALANA DE CIRURGIA
Funding: 12000
Reference: SCCOT-2012-01
Duration: 01/11/2012 - 31/10/2013

Red Temática de Investigación Cooperativa en Cáncer (RTICC)

IP: Santiago Ramon y Cajal Agüeras
Collaborators: Cleofé Romagosa Pérez-Portabell, Maria Rosa Somoza Lopez de Haro, Meritxell Bellet Ezquerra, Cristina Saura Manich, Angel García Jiménez, Patricia Gómez Pardo, Red Temática de Investigación Cooperativa en Cáncer (RTICC), Teresa Moline Marimon, Josep Castellví Vives, Judith Balmaña Gelpí, Pere Barba Suñol, Eva Muñoz Couselo, Javier Hernandez Losa, Marta Sese Faustino, Vicente Peg Camara, Stefania Landolfi , Trond Aasen
Funding agency: Instituto de Salud Carlos III
Funding: 209700
Reference: RD12/0036/0057
Duration: 01/01/2013 - 30/06/2017

Senescencia en tumores humanos: un nuevo frente en la lucha contra el cáncer

IP: Cleofé Romagosa Pérez-Portabell
Collaborators: -
Funding agency: Fundación Caja Navarra
Funding: 7.04
Reference: CAN-2010-21163
Duration: 01/01/2011 - 31/12/2011

Related news

The ten groups within the Cancer Area combine basic, translational and clinical research to identify new targets, biomarkers and therapeutic strategies

The grants promote new therapeutic strategies and diagnostic tools in highly complex tumors such as glioblastoma, triple-negative breast cancer, and endometrial cancer.

The Department of Health of the Generalitat de Catalunya grants subsidies for carrying out validation tests on innovative projects in the field of health that are in the early stages of development.

Related professionals

David Hernandez Morales

David Hernandez Morales

Research technician
Stroke research
Read more
Concepción Gomez Gavara

Concepción Gomez Gavara

Main researcher
General Surgery
Read more
Patricia Bogdanov Baruj

Patricia Bogdanov Baruj

Postdoctoral researcher
Diabetes and Metabolism
Read more
José Ramon Jarrín Luengo

José Ramon Jarrín Luengo

Research technician
Kidney Physiopathology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.